Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 32023R0308

Commission Implementing Regulation (EU) 2023/308 of 8 February 2023 amending Annex I to Implementing Regulation (EU) 2021/403 as regards model animal health certificates for movements between Member States of consignments of cervid animals (Text with EEA relevance)

C/2023/857

OJ L 40, 10.2.2023, p. 1–17 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Legal status of the document In force

ELI: http://data.europa.eu/eli/reg_impl/2023/308/oj

10.2.2023   

EN

Official Journal of the European Union

L 40/1


COMMISSION IMPLEMENTING REGULATION (EU) 2023/308

of 8 February 2023

amending Annex I to Implementing Regulation (EU) 2021/403 as regards model animal health certificates for movements between Member States of consignments of cervid animals

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (1), and in particular Article 146(2) and Article 156(2), first subparagraph, point (a), thereof,

Whereas:

(1)

Commission Implementing Regulation (EU) 2021/403 (2) establishes, amongst other things, model animal health certificates for movements between Member States of consignments of certain categories of terrestrial animals.

(2)

In particular, Article 6 of Implementing Regulation (EU) 2021/403 provides that the animal health certificates to be used for movements between Member States of certain categories of ungulates are to correspond to one of the models set out in Annex I to that Implementing Regulation, depending on the species concerned. Chapters 11 and 12 of that Annex set out, respectively, model animal health certificates for movements between Member States of cervid animals not intended for slaughter (model ‘CER-INTRA-X’), and of cervid animals intended for slaughter (model ‘CER-INTRA-Y’).

(3)

Annexes VIII and IX to Regulation (EC) No 999/2001 of the European Parliament and of the Council (3) were recently amended by Commission Regulation (EU) 2022/2246 (4) to restrict movements of cervid animals in conjunction with human activity between Norway which is currently affected by outbreaks of chronic wasting disease (CWD) in those animals, as well as those Member States which are also currently affected by outbreaks of CWD, and the other Member States unaffected by CWD. This movement restriction is necessary to prevent the spread of CWD in the Union. Accordingly, models ‘CER-INTRA-X’ and ‘CER-INTRA-Y’ set out in Annex I to Implementing Regulation (EU) 2021/403 should be amended in order to reflect that movement restriction.

(4)

Implementing Regulation (EU) 2021/403 should therefore be amended accordingly.

(5)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

Annex I to Implementing Regulation (EU) 2021/403 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 8 February 2023.

For the Commission

The President

Ursula VON DER LEYEN


(1)   OJ L 84, 31.3.2016, p. 1.

(2)  Commission Implementing Regulation (EU) 2021/403 of 24 March 2021 laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates and model animal health/official certificates, for the entry into the Union and movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof, official certification regarding such certificates and repealing Decision 2010/470/EU (OJ L 113, 31.3.2021, p. 1).

(3)  Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (OJ L 147, 31.5.2001, p. 1).

(4)  Commission Regulation (EU) 2022/2246 of 15 November 2022 amending Annexes VIII and IX to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards chronic wasting disease in live cervids (OJ L 295, 16.11.2022, p. 1).


ANNEX

In Annex I to Implementing Regulation (EU) 2021/403, Chapters 11 and 12 are replaced by the following:

‘CHAPTER 11

MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN MEMBER STATES OF CERVID ANIMALS NOT INTENDED FOR SLAUGHTER (MODEL ‘CER-INTRA-X’)

Image 1

Image 2

EUROPEAN UNION

Certificate model CER-INTRA-X

 

II. Health information

II.a

Certificate reference

II.b

IMSOC reference

Part II: Certification

I, the undersigned official veterinarian, hereby certify that:

II.1.

The cervid animals (1) of the consignment described in Part I meet the following requirements:

II.1.1.

They are identified as provided for in Article 73 or Article 74 of Commission Delegated Regulation (EU) 2019/2035.

II.1.2.

They, for the period of at least the 30 days prior to the date of departure of the consignment, or since birth, if they are younger than 30 days of age,

II.1.2.1.

have been continuously resident in the establishment of origin;

II.1.2.2.

have not been in contact with kept cervid animals of a lower health status or subject to movement restrictions for animal health reasons;

II.1.2.3.

have not been in direct or indirect contact with kept animals that have entered the Union from a third country or territory during the period of 30 days prior to the date of departure of the consignment.

II.1.3.

They have not shown clinical signs or symptoms of diseases listed for cervid animals during the clinical examination which was carried out, within the period of 24 hours prior to the date of departure of the consignment, on ………………. (insert date dd/mm/yyyy).

II.2.

According to official information, the animals described in Part I meet the following health requirements:

II.2.1.

They do not come from establishments subject to movement restrictions affecting the species or situated in a restricted zone established for reasons of diseases listed for cervid animals.

II.2.2.

They come from establishments in which infection with Brucella abortus, B. melitensis and B. suis in cervid animals has not been reported during the period of the last 42 days prior to the date of departure of the consignment.

II.2.3.

They come from establishments in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried out on the cervid animals kept on the establishments during the period of at least 12 months prior to the date of departure of the consignment, as referred to in Article 26(1), point (e), of Commission Delegated Regulation (EU) 2020/688.

II.2.4.

They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the period of 30 days prior to the date of departure of the consignment.

II.2.5.

They come from establishments situated in an area of at least 150 km radius around those establishments in which infection with epizootic haemorrhagic disease virus has not been reported in any establishment during the period of the last 2 years prior to the date of departure of the consignment.

II.2.6.

They come from establishments in which anthrax in ungulates has not been reported during the period of 15 days prior to the date of departure of the consignment.

II.2.7.

They come from establishments in which surra (Trypanosoma evansi) has not been reported during the period of 30 days prior to the date of departure of the consignment, and:

(2) either

[surra has not been reported in the establishments during the period of the last 2 years prior to the date of departure of the consignment.]

(2) or

[surra has been reported during the period of the last 2 years prior to the date of departure of the consignment, following the date of the last outbreak the affected establishments have remained under movement restrictions until:

the date on which the infected animals have been removed from the establishments, and

the date on which the remaining animals on the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken during the period of at least 6 months after the date on which the infected animals have been removed from the establishments.]

(2) either [II.2.8.

They originate from a Member State or a zone thereof free from infection with bluetongue virus (serotypes 1-24), where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the period of 24 months prior to the date of departure of the consignment and have not been vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1-24) during the period of 60 days prior to the date of departure of the consignment and the requirements laid down in Article 32(1), points (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.]

(2) and/or [II.2.8.

They originate from a Member State or a zone thereof covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), points (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they:

(2) either [II.2.8.1.

have been kept in a Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24) in accordance with Article 40(3) of Commission Delegated Regulation (EU) 2020/689:

(2) either [II.2.8.1.1.

for the period of at least 60 days prior to the date of departure of the consignment;]]

(2) and/or [II.2.8.1.2.

for the period of at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected during the period of at least 28 days following the date of entry of the animal into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]

(2) and/or [II.2.8.1.3.

for the period of at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected during the period of at least 14 days following the date of entry of the animal into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]]

(2) and/or [II.2.8.2.

have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:

(2) either [II.2.8.2.1.

for the period of at least 60 days prior to the date of departure of the consignment;]]

(2) and/or [II.2.8.2.2.

for the period of at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected during the period of at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]

(2) and/or [II.2.8.2.3.

for the period of at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected during the period of at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]

(2) and/or [II.2.8.3.

have been vaccinated against those serotypes from 1 to 24 of infection with bluetongue virus which were reported during the period of 2 years in that Member State or zone thereof prior to the date of departure of the consignment and are within the period of immunity guaranteed in the specifications of the vaccine, and:

(2) either [II.2.8.3.1.

have been vaccinated during the period of more than 60 days prior to the date of departure of the consignment;]]

(2) and/or [II.2.8.3.2.

have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected during the period of at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]

(2) and/or [II.2.8.4.

have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1-24 of infection with bluetongue virus reported in that Member State or zone thereof during the period of 2 years prior to the date of departure of the consignment, and:

(2) either [II.2.8.4.1.

the serological test has been carried out on samples collected during the period of at least 60 days prior to the date of departure of the consignment;]]

(2) and/or [II.2.8.4.2.

the serological test has been carried out on samples collected during the period of at least 30 days prior to the date of departure of the consignment and the animal has been subjected to a PCR test, with negative results, carried out on samples collected during the period of not earlier than 14 days prior to the date of departure of the consignment;]]]

(2) and/or [II.2.8.

They originate from a Member State or a zone thereof neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), points (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they:

(2) either [II.2.8.1.

have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment:

(2) either [II.2.8.1.1.

for the period of at least 60 days prior to the date of departure of the consignment;]]

(2) and/or [II.2.8.1.2.

for the period of at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected during the period of at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]]

(2) and/or [II.2.8.1.3.

for the period of at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected during the period of at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]]

(2) and/or [II.2.8.2.

have been kept for the period of 60 days prior to the date of departure of the consignment in an establishment situated in a Member State or in an area of at least 150 km radius centred on the establishment, where surveillance in compliance with the requirements set out in Part II, Chapter 1, Sections 1 and 2, of Annex V to Delegated Regulation (EU) 2020/689 has been carried out during that period, and:

(2) either [II.2.8.2.1.

the animals have been vaccinated against those serotypes from 1 to 24 of infection with bluetongue virus which were reported during the period of 2 years prior to the date of departure of the consignment in an area of at least 150 km radius centred on the place where the animals were kept and are within the period of immunity guaranteed in the specifications of the vaccine, and:

(2) either [II.2.8.2.1.1.

have been vaccinated during the period of more than 60 days prior to the date of departure of the consignment;]]]

(2) and/or [II.2.8.2.1.2.

have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected during the period of at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]]

(2) and/or [II.2.8.2.2.

the animals have been immunised against those serotypes from 1 to 24 of infection with bluetongue virus which were reported during the period of the past 2 years prior to the date of departure of the consignment in an area of at least 150 km radius centred on the place where the animals were kept, and:

(2) either [II.2.8.2.2.1.

the animals have been subjected with positive results to a serological test carried out on samples collected during the period of at least 60 days prior to the date of departure of the consignment;]]]

(2) and/or [II.2.8.2.2.2.

the animals have been subjected with positive results to a serological test carried out on samples collected during the period of at least 30 days prior to the date of departure of the consignment and to a PCR test, with negative results, carried out on samples collected during the period of not earlier than 14 days prior to the date of departure of the consignment.]]]]

(2) and/or [II.2.8.

They do not fulfil the requirements laid down in Part II, Chapter 2, Section 1, points 1 to 3, of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of the Member State of origin authorised movement of those animals to another Member State or zone thereof:

(2) either [II.2.8.1.

with the status free from infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and in:

(2) either [II.2.8.1.1.

Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation;]]

(2) and/or [II.2.8.1.2.

Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation;]]

(2) and/or [II.2.8.1.3.

Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation;]]

(2) and/or [II.2.8.1.4.

Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and the requirements laid down in Article 32(1), points (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of Delegated Regulation (EU) 2020/688 are fulfilled;]]]

(2) and/or [II.2.8.2.

with an approved eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689 and in

(2) either [II.2.8.2.1.

Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation;]]

(2) and/or [II.2.8.2.2.

Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation;]]

(2) and/or [II.2.8.2.3.

Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation;]]

(2) and/or [II.2.8.2.4.

Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and the requirements laid down in Article 32(1), points (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of Delegated Regulation (EU) 2020/688 are fulfilled;]]]

(2) and/or [II.2.8.3.

neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised:

(2) either [II.2.8.3.1.

without any conditions;]]

(2) and/or [II.2.8.3.2.

subject to the conditions referred to in Part II, Chapter 2, Section 1, point 5, of Annex V to Delegated Regulation (EU) 2020/689;]]

(2) and/or [II.2.8.3.3.

subject to the conditions referred to in Part II, Chapter 2, Section 1, point 6, of Annex V to Delegated Regulation (EU) 2020/689;]]

(2) and/or [II.2.8.3.4.

subject to the conditions referred to in Part II, Chapter 2, Section 1, point 7, of Annex V to Delegated Regulation (EU) 2020/689;]]

(2) and/or [II.2.8.3.5.

subject to the conditions referred to in Part II, Chapter 2, Section 1, point 8, of Annex V to Delegated Regulation (EU) 2020/689, and the requirements laid down in Article 32(1), points (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of Delegated Regulation (EU) 2020/688 are fulfilled.]]]

II.2.9.

With regard to chronic wasting disease (CWD), they:

(2) either [II.2.9.1.

are moved from a Member State other than a Member State listed in Chapter A, Section C, point 1.1, of Annex VIII to Regulation (EC) No 999/2001 of the European Parliament and of the Council.]

(2) or [II.2.9.2.

are semi-domesticated reindeer moved from Norway to an area in Finland listed in Chapter A, Section C, point 1.2(a), of Annex VIII to Regulation (EC) No 999/2001 for seasonal grazing in Finland.]

(2) or [II.2.9.3.

are semi-domesticated reindeer moved from Norway to an area in Sweden listed in Chapter A, Section C, point 1.2(b), of Annex VIII to Regulation (EC) No 999/2001 after seasonal grazing in Norway, or after having taken part in sporting or cultural events in Norway, or for seasonal grazing in Sweden, or for sporting or cultural events in Sweden, and the competent authority of Sweden has given its prior written consent to such movement.]

(2) or [II.2.9.4.

are semi-domesticated reindeer which have grazed in Norway in the area located between the Norwegian-Finnish border, and the Norwegian-Finnish Reindeer Fence and are returning to Finland.]

(2) or [II.2.9.5.

are moved from an area in Norway to another area in Norway with a transit through Sweden or Finland, and the competent authority of Sweden or Finland has given its prior written consent to such transit.]

(2) or [II.2.9.6.

are moved from an area in Sweden listed in Chapter A, Section C, point 1.2(b), of Annex VIII to Regulation (EC) No 999/2001 to Norway, and the competent authority of Norway has given its prior written consent to such movement.]

(2) or [II.2.9.7.

are forest reindeer moved from an area in Sweden listed in Chapter A, Section C, point 1.2(b), of Annex VIII to Regulation (EC) No 999/2001 to Finland, and the competent authority of Finland has given its prior written consent to such movement.]

(2) or [II.2.9.8.

are moved from an area in a Member State listed in Chapter A, Section C, point 1.1, of Annex VIII to Regulation (EC) No 999/2001, other than an area listed in Chapter A, Section C, point 1.2, of Annex VIII to that Regulation, to another Member State listed in Chapter A, Section C, point 1.1, of Annex VIII to that Regulation, or to Norway, and the competent authority of destination has given its prior written consent to such movement.]

(2) or [II.2.9.9.

are moved from a confined establishment, as defined in Article 4(48) of Regulation (EU) 2016/429, in a Member State listed in Chapter A, Section C, point 1.1, of Annex VIII to Regulation (EC) No 999/2001, to a confined establishment, as defined in Article 4(48) of Regulation (EU) 2016/429, in another Member State, and the competent authority of the Member State of destination has given its prior written consent to such movement.]

(2) [II.2.10.

They are moved to a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis or with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine animals and they come from an establishment in which infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in cervid animals has not been reported during the period of 30 days prior to the date of departure of the consignment.]

II.3.

To the best of my knowledge and as declared by the operator, the animals come from establishments where there were no abnormal mortalities with an undetermined cause.

II.4.

Arrangements are made to transport the consignment in accordance with Article 4 of Delegated Regulation (EU) 2020/688.

II.5.

This animal heath certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of animals, the period of validity of the certificate may be extended by the duration of the journey by waterway/sea.

(2) (3) [II.6.

Since the date of leaving their establishments of origin and prior to the date of arrival to this establishment approved for assembly operations, none of the animals of the consignment has undergone more than two assembly operations, and:

(2) either

[they come from their establishments of origin.]]

(2) or

[at least one of the animals of the consignment has undergone one assembly operation in an approved establishment.]]

(2) or

[at least one of the animals of the consignment has undergone two assembly operations in the approved establishments.]]

Animal welfare attestation

At the time of inspection, the animals covered by this animal health certificate were fit to be transported in accordance with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start on …………… (insert date).

Notes:

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, references to European Union in this animal health certificate include the United Kingdom in respect of Northern Ireland.

This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235.

Part I:

Box reference I.11:

‘Place of dispatch’: Indicate an establishment of the origin of the animals in the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429 of the European Parliament and of the Council.

Box reference I.12:

‘Place of destination’: Indicate an establishment of the final destination of the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429.

Box reference I.17:

‘Accompanying documents’: In case the animals are dispatched from an establishment approved for assembly operations in the Member State of origin, the reference number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, may be indicated.

In case the animals are dispatched from an establishment approved for assembly operations in the Member State of passage, the reference number(s) of the certificate(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, must be indicated.

Box reference I.30:

‘Identification number’: Indicate identification codes of the animals in the consignment identified in accordance with Article 73 or Article 74 of Delegated Regulation (EU) 2019/2035.

Part II:

(1)

There can be one or more animals in the consignment.

(2)

Delete if not applicable.

(3)

Applicable in case the consignment is dispatched from the establishment approved for assembly operations.

 

Official veterinarian

Name (in capital letters)

 

Qualification and title

 

Local Control Unit name

 

Local Control Unit code

 

Date

 

 

 

Stamp

 

Signature

 

CHAPTER 12

MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN MEMBER STATES OF CERVID ANIMALS INTENDED FOR SLAUGHTER (MODEL ‘CER-INTRA-Y’)